Kevin Strang

Stock Analyst at Goldman Sachs

(0.53)

# 4,296

Out of 5,116 analysts

8

Total ratings

16.7%

Success rate

-21.2%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Kevin Strang

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	STOK Stoke Therapeutics	Reiterated: Buy	$44 → $43	$26.54	+62.02%	4	Oct 30, 2026
	PRAX Praxis Precision Medicines	Rated: Buy	$470 → $575	$277.62	+107.12%	4	Aug 21, 2026

Stoke Therapeutics

Oct 30, 2026

Reiterated: Buy

Price Target: $44 → $43

Current: $26.54

Upside: +62.02%

Praxis Precision Medicines

Aug 21, 2026

Rated: Buy

Price Target: $470 → $575

Current: $277.62

Upside: +107.12%